Citations 1
SWOG 99–16: Randomized phase III trial of docetaxel (D)/estramustine (E) versus mitoxantrone(M)/prednisone(p) in men with androgen-independent prostate cancer (AIPCA)
Petrylak, D. P., Tangen, C., Lara, P. N. , Jones, J., Talpin, M. E., Burch, P., Greene, G., Crawford, E. D., Hussain, Maha , Burch, P. A., Small, Eric J.
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3-3
